Investors Asset Management of Georgia’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Investors Asset Management of Georgia’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,500	Closed	-$29.7K	–	178
2022 Q4	$29.7K	Hold	33,500	–	–	0.02%	166
2022 Q3	$53K	Hold	33,500	–	–	0.03%	292
2022 Q2	$67K	Buy	33,500 +6,000	+22%	+$10.4K	0.03%	240
2022 Q1	$64K	Buy	27,500 +4,500	+20%	+$14K	0.03%	170
2021 Q4	$107K	Buy	+23,000	New	+$143K	0.05%	168

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Investors Asset Management of Georgia's SRNE Position: Q1 2023 in Review

Investors Asset Management of Georgia sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 33,500 shares — an estimated $29.7K sold.

Investors Asset Management of Georgia first reported a position in SRNE in Q4 2021 and held it in 5 quarters. The position peaked at $107K in Q4 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Investors Asset Management of Georgia reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Investors Asset Management of Georgia sold 33,500 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $29.7K.
Investors Asset Management of Georgia first reported a position in Sorrento Therapeutics, Inc. in Q4 2021 and held it in 5 quarters.
Investors Asset Management of Georgia's Sorrento Therapeutics, Inc. position peaked at $107K in Q4 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Investors Asset Management of Georgia's 13F filing for Q1 2023, filed 1 May 2023.